Cases 31 - 40 of 331
Bristol-Myers Squibb Company et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00410
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
Teva Pharmaceuticals USA, Inc.
Counter_claimant:
Teva Pharmaceuticals USA, Inc.
Counter_defendant:
Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
ASTRAZENECA PHARMACEUTICALS LP et al v. TEVA PHARMACEUTICALS USA, INC.
as 1:2017cv02448
Plaintiff:
ASTRAZENECA PHARMACEUTICALS LP , ASTRAZENECA UK LIMITED and ASTRAZENECA AB
Defendant:
TEVA PHARMACEUTICALS USA, INC.
Cause Of Action: 15 U.S.C. § 1126
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00393
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Glaxo Group Ltd. v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00357
Plaintiff:
Glaxo Group Ltd.
Defendant:
Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Galderma Laboratories LP v Actavis Laboratories UT Inc et al
as 3:2017cv00903
Plaintiff:
Galderma Laboratories LP , Galderma SA and Galderma Research & Development SNC
Defendant:
Actavis Laboratories UT Inc, TEVA Pharmaceuticals USA Inc and TEVA Pharmaceuticals Industries LTD
Cause Of Action: 35 U.S.C. § 271
ELI LILLY AND COMPANY v. ACTAVIS LLC et al
as 1:2017cv00982
Defendant:
ACTAVIS LLC, TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICAL INDUSTRIES LTD.
Plaintiff:
ELI LILLY AND COMPANY
Cause Of Action: 35 U.S.C. § 145
Salix Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00329
Plaintiff:
Salix Pharmaceuticals, Inc. and Dr. Falk Pharma GmbH
Defendant:
Teva Pharmaceuticals USA, Inc.
Counter_claimant:
Teva Pharmaceuticals USA, Inc.
Counter_defendant:
Dr. Falk Pharma GmbH and Salix Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
BioDelivery Sciences International, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2017cv00282
Plaintiff:
BioDelivery Sciences International, Inc. and Arius Two, Inc.
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS LABORATORIES UT, INC. et al
as 2:2017cv01706
Plaintiff:
DOW PHARMACEUTICAL SCIENCES, INC. and VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Defendant:
ACTAVIS LABORATORIES UT, INC. , ACTAVIS LLC , TEVA PHARMACEUTICALS USA, INC. and others
Cause Of Action: 15 U.S.C. § 1126
Teva Pharmaceuticals USA, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00249
Plaintiff:
Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd. and Teva Neuroscience, Inc.
Defendant:
Mylan Pharmaceuticals Inc. , Mylan Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
